drugset / Trial / NCT00737971
Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema
RandomizedParallel-groupDouble-blindTreatment
Summary
Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema
Timeline
- Start
- 2008-08
- Primary completion
- 2012-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bevacizumab | Monoclonal antibody | 0.05 ml | Intravitreal |
| Comparator | Bevacizumab | Monoclonal antibody | 1.25 mg | Intravitreal |
| Comparator | Triamcinolone | Other / unclassified | 0.1 ml | Intravitreal |
| Comparator | Triamcinolone | Other / unclassified | 4 mg | Intravitreal |